Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06575842 · ClinicalTrials.gov registry record

Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes

A clinical trial of Type 1 Diabetes, sponsored by University of Colorado, Denver.

Recruiting
Registry status
120
Enrollment target
1
Study location

NCT06575842: Recruiting study of Type 1 Diabetes, sponsored by University of Colorado, Denver.

NCT06575842 is a study of Type 1 Diabetes that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 120 participants, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06575842, a study of Type 1 Diabetes, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.

Primary Outcome

Accuracy assessment will be completed comparing CGM glucose values to blood glucose values using standard statistical assessments.

Conditions Studied

Study Locations (1)

Colorado

  • Barbara Davis Center - Aurora

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-08-21
Est. Completion 2025-09-01
University of Colorado, Denver

1,283 total trials

What NCT06575842 shows while recruiting

NCT06575842 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 0 interventions.

NCT06575842 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT06575842 about?

NCT06575842 is a clinical study titled "Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes". This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.

What is the current status of trial NCT06575842?

This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2024-08-21. Estimated completion is 2025-09-01.

What conditions does trial NCT06575842 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

Who is sponsoring clinical trial NCT06575842?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06575842 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06575842's enrollment target sits among peer trials

120 47th of 198 higher than 151 of 198 other Type 1 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06575842, the US trial registry maintained by the National Library of Medicine. NCT06575842 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.